Biogen (BIIB)

Total Liabilities

$13.24B

Quarterly · Period ending: · USD

BIIB logo

BIIB Total Liabilities

Latest reported$13.24B
BIIB Quarterly Total Liabilities ($10.90M → $13.24B)
High-resolution chart · PNG

BIIB total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
13,238,600,000
10,831,400,000
11,182,700,000
11,000,000,000
10,696,200,000
11,054,400,000
11,333,300,000
11,954,300,000
10,915,000,000
11,354,600,000
12,045,400,000
13,713,500,000
10,696,300,000
10,811,400,000
11,165,700,000
12,087,400,000
13,218,000,000
12,393,700,000
12,917,600,000
12,925,000,000
13,255,600,000
13,191,500,000
13,932,800,000
14,189,600,000
14,222,600,000
13,582,300,000
13,895,200,000
13,492,200,000
13,338,800,000
12,623,500,000
12,257,300,000
11,732,400,000
11,699,200,000
12,052,600,000
11,054,500,000
10,224,300,000
10,185,400,000
9,728,500,000
10,748,200,000
9,990,100,000
10,111,100,000
10,346,600,000
10,129,900,000
10,161,425,000
4,186,173,000
3,549,996,000
3,502,519,000
3,273,257,000
3,352,772,000
3,089,068,000
3,242,497,000
3,124,561,000
2,939,445,000
2,825,111,000
3,166,323,000
2,968,681,000
2,891,695,000
2,805,001,000
2,622,617,000
2,568,610,000
2,565,785,000
2,619,224,000
2,643,050,000
2,323,946,000
2,290,860,000
2,266,729,000
2,289,972,000
2,428,627,000
2,531,491,000
2,554,952,000
2,672,908,000
2,766,730,000
2,649,895,000
2,637,945,000
3,094,520,000
2,823,676,000
4,299,016,000
1,362,414,000
1,403,030,000
1,291,684,000
1,331,571,000
1,381,384,000
1,461,071,000
1,516,782,000
1,522,338,000
2,281,735,000
2,339,357,000
2,310,336,000
2,293,175,000
2,314,122,000
2,450,617,000
373,321,000
328,206,000
357,210,000
411,567,000
341,853,000
363,248,000
350,382,000
372,214,000
352,116,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.